Clinical trial
A Randomized, Multi-Center, Phased, Pivotal Safety and Efficacy Study Comparing the Elipse™ Gastric Balloon System vs. Sham for the Treatment of Obese Adults
NCT03261453 is registered in ClinicalTrials.gov with Allurion Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multi-Center, Phased, Pivotal Safety and Efficacy Study Comparing the Elipse™ Gastric Balloon System vs. Sham for the Treatment of Obese Adults
- Lead sponsor
- Allurion Technologies
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2018
- Completion date
- May 1, 2019
- Enrollment
- 400 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.